Drug intelligence / Profile preview

Nasafytol

Development stage
Unknown
Lead developer
Tilman
Modality
Small Molecules
Administration
Oral
01

Overview

Nasafytol is an oral combination dietary supplement containing **quercetin**, **curcumin** (from turmeric extract), and **vitamin D3**. It is designed to support the immune system, respiratory function, and reduce allergic symptoms. Recent clinical studies in adults—especially among those with COVID-19—have shown that Nasafytol can expedite symptom resolution and viral clearance when used as an adjunct to standard medical care. Its mechanism of action includes providing synergistic **anti-inflammatory**, **antioxidant**, **immunomodulatory**, and **antiviral** effects through its components: - Quercetin is a polyphenol known for broad-spectrum anti-viral, anti-inflammatory, and antioxidant effects. - Curcumin exerts anti-inflammatory and antioxidant effects, and supports lung and immune health. - Vitamin D3 modulates immune response and supports normal immune system function[1][2][3][5][7].

Brand names
Nasafytol
Other names
Nasafytol
02

Targets

VDR (Vitamin D receptor)Mpro (3C-like proteinase of SARS-CoV-2)RdRp (Coronavirus RNA-dependent RNA polymerase)Angiotensin-converting enzyme 2–SARS-CoV-2 spike protein interaction interface

Beyond the preview

Go deeper on Nasafytol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nasafytol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call